TY  - JOUR 
AU  - Torrente López, Anabel
AU  - Hermosilla Fernández, Jesús
AU  - Pérez Robles, Raquel
AU  - Salmerón García, Antonio
AU  - Cabeza, José
AU  - Navas Iglesias, Natalia Africa
PY  - 2022
UR  - http://hdl.handle.net/10481/76503
AB  - Nivolumab (Opdivo®) is a fully human immunoglobulin G4 isotype approved for the treatment of many cancers.
It acts as an immune checkpoint inhibitor by blocking the interaction between PD-1 (Programmed Cell Death
Protein 1) – an inhibitory receptor...
LA  - eng
PB  - Elsevier
KW  - UV/MS data combined use
KW  - Quantification
KW  - Isoform profile identification
KW  - LC-MS
KW  - Nivolumab
TI  - Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab
DO  - 10.1016/j.microc.2022.107896
ER  -